282 related articles for article (PubMed ID: 24268666)
1. Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3.
Yu YP; Wang Q; Liu YC; Xie Y
Biomaterials; 2014 Feb; 35(5):1667-75. PubMed ID: 24268666
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
Liu S
Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
[TBL] [Abstract][Full Text] [Related]
3. Interaction Mechanism and Clustering among RGD Peptides and Integrins.
Dong X; Yu Y; Wang Q; Xi Y; Liu Y
Mol Inform; 2017 May; 36(5-6):. PubMed ID: 28004516
[TBL] [Abstract][Full Text] [Related]
4. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
Choi Y; Kim E; Lee Y; Han MH; Kang IC
Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin.
Cody V; Davis PJ; Davis FB
Steroids; 2007 Feb; 72(2):165-70. PubMed ID: 17166537
[TBL] [Abstract][Full Text] [Related]
6. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.
Liu S
Bioconjug Chem; 2009 Dec; 20(12):2199-213. PubMed ID: 19719118
[TBL] [Abstract][Full Text] [Related]
9. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.
Danhier F; Le Breton A; Préat V
Mol Pharm; 2012 Nov; 9(11):2961-73. PubMed ID: 22967287
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.
Jin YC; Lee H; Kim SW; Kim ID; Lee HK; Lee Y; Han PL; Lee JK
Mol Neurobiol; 2016 Oct; 53(8):5652-63. PubMed ID: 26482372
[TBL] [Abstract][Full Text] [Related]
11. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924
[TBL] [Abstract][Full Text] [Related]
12. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
Raj A; Saraf P; Javali NM; Li X; Jasti B
J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
[TBL] [Abstract][Full Text] [Related]
13. RGD peptide-based non-viral gene delivery vectors targeting integrin α
Fu S; Xu X; Ma Y; Zhang S; Zhang S
J Drug Target; 2019 Jan; 27(1):1-11. PubMed ID: 29564914
[TBL] [Abstract][Full Text] [Related]
14. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
15. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.
Xiang M; Lin Y; He G; Chen L; Yang M; Yang S; Mo Y
J Mol Model; 2012 Nov; 18(11):4917-27. PubMed ID: 22736220
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel dual-cyclic RGD peptides for α
Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the interaction between RGD-expressing adenovirus type 5 fiber knob domains and alphavbeta3 integrin reveals distinct binding profiles and intracellular trafficking.
Lord R; Parsons M; Kirby I; Beavil A; Hunt J; Sutton B; Santis G
J Gen Virol; 2006 Sep; 87(Pt 9):2497-2505. PubMed ID: 16894187
[TBL] [Abstract][Full Text] [Related]
18. The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle.
Xiao W; Wang Y; Lau EY; Luo J; Yao N; Shi C; Meza L; Tseng H; Maeda Y; Kumaresan P; Liu R; Lightstone FC; Takada Y; Lam KS
Mol Cancer Ther; 2010 Oct; 9(10):2714-23. PubMed ID: 20858725
[TBL] [Abstract][Full Text] [Related]
19. Design of integrin α
Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
